⌘K

Login Start Free

Home/Filings/4/0000875320-24-000168

4//SEC Filing

Tatsis Ourania 4

Accession 0000875320-24-000168

CIK 0000875320other

View on SEC.gov Company Profile

Filed

Jun 4, 8:00 PM ET

Accepted

Jun 5, 4:08 PM ET

Size

4.7 KB

Accession

0000875320-24-000168

Insider Transaction Report

Form 4

Period: 2024-06-03

VERTEX PHARMACEUTICALS INC / MAVRTX

EVP, Chief Reg. & Quality Off.

Transactions

Sale
Common Stock
2024-06-03$460.00/sh−2,175$1,000,500→ 49,098 total

Footnotes (1)

[F1]Transaction made pursuant to Ms. Tatsis' company approved trading plan under Rule 10b5-1, which was entered into on 02/29/2024.

Documents

1 file

4
wk-form4_1717618128.xmlPrimary
FORM 4

Issuer

VERTEX PHARMACEUTICALS INC / MA

CIK 0000875320

Entity typeother

Related Parties

1

filerCIK 0001789815

Filing Metadata

Form type: 4
Filed: Jun 4, 8:00 PM ET
Accepted: Jun 5, 4:08 PM ET
Size: 4.7 KB

View on SEC.gov